Advertisement
Review Article| Volume 34, ISSUE 1, P189-203, February 2020

Contemporary Topics in Radiation Medicine

Skin Cancer

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Hematology/Oncology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Leiter U.
        • Eigentler T.
        • Garbe C.
        Epidemiology of skin cancer.
        Adv Exp Med Biol. 2014; 810: 120-140
        • Apalla Z.
        • et al.
        Skin cancer: epidemiology, disease burden, pathophysiology, diagnosis, and therapeutic approaches.
        Dermatol Ther. 2017; 7: 5-19
        • Awad R.
        • Andrade J.C.B.
        • Mousa H.
        • et al.
        Invasive basal cell carcinoma of the skin treated successfully with vismodegib: a case report.
        Perm J. 2018; 22: 17-181
        • Wang Y.J.
        • Tang T.Y.
        • Wang J.Y.
        • et al.
        Genital basal cell carcinoma, a different pathogenesis from sun-exposed basal cell carcinoma? A case-control study of 30 cases.
        J Cutan Pathol. 2018; https://doi.org/10.1111/cup.13304
        • Network, N.C.C
        Basal cell skin cancer (Version 1.2019).
        (Available at:) (Accessed March 24, 2019)
        • Marks R.
        • Rennie G.
        • Selwood T.S.
        Malignant transformation of solar keratoses to squamous cell carcinoma.
        Lancet. 1988; 1: 795-797
        • Pekarek B.
        • Buck S.
        • Osher L.
        A comprehensive review on Marjolin's ulcers: diagnosis and treatment.
        J Am Col Certif Wound Spec. 2011; 3: 60-64
        • Jennings L.
        • Schmults C.D.
        Management of high-risk cutaneous squamous cell carcinoma.
        J Clin Aesthet Dermatol. 2010; 3: 39-48
        • Eigentler T.K.
        • Leiter U.
        • Häfner H.M.
        • et al.
        Survival of patients with cutaneous squamous cell carcinoma: results of a prospective cohort study.
        J Invest Dermatol. 2017; 137: 2309-2315
      1. AJCC cancer staging manual. In Amin MB, Edge S, Greene F, et al, Editors, 8th edition, New York: Springer Publishing.

        • Ahmed I.
        • Berth-Jones J.
        • Charles-Holmes S.
        • et al.
        Comparison of cryotherapy with curettage in the treatment of Bowen's disease: a prospective study.
        Br J Dermatol. 2000; 143: 759-766
        • Overmark M.
        • Koskenmies S.
        • Pitkanen S.
        A retrospective study of treatment of squamous cell carcinoma in situ.
        Acta Derm Venereol. 2016; 96: 64-67
      2. Network, N.C.C., Squamous Cell Skin Cancer (Version 2.2019). 2019.

        • Nehal K.S.
        • Bichakjian C.K.
        Update on keratinocyte carcinomas.
        N Engl J Med. 2018; 379: 363-374
        • Jackson J.E.
        • Dickie G.J.
        • Wiltshire K.L.
        • et al.
        Radiotherapy for perineural invasion in cutaneous head and neck carcinomas: toward a risk-adapted treatment approach.
        Head Neck. 2009; 31: 604-610
        • Reule R.B.
        • Golda N.J.
        • Wheeland R.G.
        Treatment of cutaneous squamous cell carcinoma with perineural invasion using Mohs micrographic surgery: report of two cases and review of the literature.
        Dermatol Surg. 2009; 35: 1559-1566
        • Han A.
        • Ratner D.
        What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion?.
        Cancer. 2007; 109: 1053-1059
        • Manyam B.V.
        • Nikhil J.
        • Koyfman S.A.
        A review of the role of external-beam radiation therapy in nonmelanomatous skin cancer.
        Appl Rad Oncol. 2017; 6: 6-10
        • Howle J.
        • Veness M.
        Cutaneous carcinomas.
        in: Leonard Gunderson J.T. Clinical radiation oncology. Elsevier, 2015: 763-777
        • Hogstrom K.R.
        • Almond P.R.
        Review of electron beam therapy physics.
        Phys Med Biol. 2006; 51: R455-R489
        • van Hezewijk M.
        • Creutzberg C.L.
        • Putter H.
        • et al.
        Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: analysis of 434 cases.
        Radiother Oncol. 2010; 95: 245-249
        • Khan L.
        • Choo R.
        • Breen D.
        • et al.
        Recommendations for CTV margins in radiotherapy planning for non melanoma skin cancer.
        Radiother Oncol. 2012; 104: 263-266
        • Gluck I.
        • Ibrahim M.
        • Popovtzer A.
        • et al.
        Skin cancer of the head and neck with perineural invasion: defining the clinical target volumes based on the pattern of failure.
        Int J Radiat Oncol Biol Phys. 2009; 74: 38-46
        • Zaorsky N.G.
        • Lee C.T.
        • Zhang E.
        • et al.
        Skin CanceR Brachytherapy vs External beam radiation therapy (SCRiBE) meta-analysis.
        Radiother Oncol. 2018; 126: 386-393
        • Ouhib Z.
        • Kasper M.
        • Perez Calatayud J.
        • et al.
        Aspects of dosimetry and clinical practice of skin brachytherapy: the American Brachytherapy Society working group report.
        Brachytherapy. 2015; 14: 840-858
        • Skowronek J.
        Brachytherapy in the treatment of skin cancer: an overview.
        Postepy Dermatol Alergol. 2015; 32: 362-367
      3. Available at: http://www.cancer.gov/types/skin/moles-fact-sheet. Accessed March 24, 2019.

        • Breslow A.
        Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.
        Ann Surg. 1970; 172: 902-908
        • Lasithiotakis K.G.
        • Leiter U.
        • Gorkievicz R.
        • et al.
        The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
        Cancer. 2006; 107: 1331-1339
        • Long G.V.
        • Menzies A.M.
        • Nagrial A.M.
        • et al.
        Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.
        J Clin Oncol. 2011; 29: 1239-1246
        • Network, N.C.C
        Cutaneous melanoma (Version 2.2019).
        (Available at:) (Accessed March 24, 2019)
        • Marsden J.R.
        • Newton-Bishop J.A.
        • Burrows L.
        • et al.
        Revised U.K. guidelines for the management of cutaneous melanoma 2010.
        Br J Dermatol. 2010; 163: 238-256
        • Voit C.A.
        • van Akkooi A.C.
        • Schäfer-Hesterberg G.
        • et al.
        Rotterdam criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma?.
        J Clin Oncol. 2009; 27: 4994-5000
        • Henderson M.A.
        • Burmeister B.H.
        • Ainslie J.
        • et al.
        Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.
        Lancet Oncol. 2015; 16: 1049-1060
        • Leroux-Kozal V.
        • Lévêque N.
        • Brodard V.
        • et al.
        Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load.
        Hum Pathol. 2015; 46: 443-453
        • Heath M.
        • Jaimes N.
        • Lemos B.
        • et al.
        Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features.
        J Am Acad Dermatol. 2008; 58: 375-381
        • Haymerle G.
        • Fochtmann A.
        • Kunstfeld R.
        • et al.
        Management of Merkel cell carcinoma of unknown primary origin: the Vienna Medical School experience.
        Eur Arch Otorhinolaryngol. 2015; 272: 425-429
        • Asgari M.M.
        • Sokil M.M.
        • Warton E.M.
        • et al.
        Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma.
        JAMA Dermatol. 2014; 150: 716-723
        • Network, N.C.C
        Merkel Cell Carcinoma (Version 2.2019).
        (Available at:) (Accessed March 24, 2019)
        • Andea A.A.
        • Coit D.G.
        • Amin B.
        • et al.
        Merkel cell carcinoma: histologic features and prognosis.
        Cancer. 2008; 113: 2549-2558
        • Liu J.
        • Larcos G.
        • Howle J.
        • et al.
        Lack of clinical impact of (18) F-fluorodeoxyglucose positron emission tomography with simultaneous computed tomography for stage I and II Merkel cell carcinoma with concurrent sentinel lymph node biopsy staging: a single institutional experience from Westmead Hospital, Sydney.
        Australas J Dermatol. 2017; 58: 99-105
        • Bhatia S.
        • Storer B.E.
        • Iyer J.G.
        • et al.
        Adjuvant radiation therapy and chemotherapy in Merkel cell carcinoma: survival analyses of 6908 cases from the national cancer data base.
        J Natl Cancer Inst. 2016; 108 ([pii:djw042])
        • Rush Z.
        • Fields R.C.
        • Lee N.
        • et al.
        Radiation therapy in the management of Merkel cell carcinoma: current perspectives.
        Expert Rev Dermatol. 2011; 6: 395-404
        • Arruda E.P.
        • Higgins K.M.
        Role of sentinel lymph node biopsy in the management of Merkel cell carcinoma.
        J Skin Cancer. 2012; 2012: 176173
        • D'Angelo S.P.
        • Russell J.
        • Lebbé C.
        • et al.
        Efficacy and safety of first-line avelumab treatment in patients with stage IV metastatic Merkel cell carcinoma: a preplanned interim analysis of a clinical trial.
        JAMA Oncol. 2018; 4: e180077
        • Nghiem P.T.
        • Bhatia S.
        • Lipson E.J.
        • et al.
        PD-1 blockade with pembrolizumab in advanced Merkel-cell carcinoma.
        N Engl J Med. 2016; 374: 2542-2552
        • Wilcox R.A.
        Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.
        Am J Hematol. 2016; 91: 151-165
        • Weinstock M.A.
        • Reynes J.F.
        The changing survival of patients with mycosis fungoides: a population-based assessment of trends in the United States.
        Cancer. 1999; 85: 208-212
        • Yamashita T.
        • Fernandes Abbade L.P.
        • Alencar Marques M.E.
        • et al.
        Mycosis fungoides and Sézary syndrome: clinical, histopathological and immunohistochemical review and update.
        An Bras Dermatol. 2012; 87: 817-830
        • Hwang S.T.
        • Janik J.E.
        • Jaffe E.S.
        • et al.
        Mycosis fungoides and Sezary syndrome.
        Lancet. 2008; 371: 945-957
        • Grace L.
        • Smith L.D.W.
        • Dabaja B.S.
        Mycosis fungoides.
        in: Leonard Gunderson J.T. Clinical radiation oncology. Elsevier, 2015: 1556-1576
        • de Coninck E.C.
        • Kim Y.H.
        • Varghese A.
        • et al.
        Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides.
        J Clin Oncol. 2001; 19: 779-784
        • Diamandidou E.
        • Colome-Grimmer M.
        • Fayad L.
        • et al.
        Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis.
        Blood. 1998; 92: 1150-1159
        • Vonderheid E.C.
        • Bernengo M.G.
        • Burg G.
        • et al.
        Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas.
        J Am Acad Dermatol. 2002; 46: 95-106
        • Olsen E.
        • Vonderheid E.
        • Pimpinelli N.
        • et al.
        Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).
        Blood. 2007; 110: 1713-1722
        • Specht L.
        • Dabaja B.
        • Illidge T.
        • et al.
        Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group.
        Int J Radiat Oncol Biol Phys. 2015; 92: 32-39
        • Cotter G.W.
        • Baglan R.J.
        • Wasserman T.H.
        • et al.
        Palliative radiation treatment of cutaneous mycosis fungoides--a dose response.
        Int J Radiat Oncol Biol Phys. 1983; 9: 1477-1480
        • Harrison C.
        • Young J.
        • Navi D.
        • et al.
        Revisiting low-dose total skin electron beam therapy in mycosis fungoides.
        Int J Radiat Oncol Biol Phys. 2011; 81: e651-e657
        • Jones G.W.
        • Kacinski B.M.
        • Wilson L.D.
        • et al.
        Total skin electron radiation in the management of mycosis fungoides: consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group.
        J Am Acad Dermatol. 2002; 47: 364-370
        • Senff N.J.
        • Noordijk E.M.
        • Kim Y.H.
        • et al.
        European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.
        Blood. 2008; 112: 1600-1609
        • Grange F.
        • Beylot-Barry M.
        • Courville P.
        • et al.
        Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
        Arch Dermatol. 2007; 143: 1144-1150
        • Grange F.
        • Joly P.
        • Barbe C.
        • et al.
        Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France.
        JAMA Dermatol. 2014; 150: 535-541
        • Kim Y.H.
        • Willemze R.
        • Pimpinelli N.
        • et al.
        TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC).
        Blood. 2007; 110: 479-484
        • Neelis K.J.
        • Schimmel E.C.
        • Vermeer M.H.
        • et al.
        Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
        Int J Radiat Oncol Biol Phys. 2009; 74: 154-158